Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects

Last updated: February 21, 2024
Sponsor: Greenyn Biotechnology Co., Ltd.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetic Kidney Disease

Diabetic Retinopathy

Diabetic Vitreous Hemorrhage

Treatment

Pumpkin seed extract (High dose)

Pumpkin seed extract (Low dose)

Placebo

Clinical Study ID

NCT05738655
A-111-110
  • Ages 20-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Fasting blood sugar levels from 100 to 125 mg/dL
  • Glycated hemoglobin levels from 5.7 to 6.4%
  • 2-hour OGTT levels from 140 to 199 mg/dL

Exclusion

Exclusion Criteria:

  • Pregnant women or preparing for pregnancy.
  • Lactating women.
  • Women gave birth 6 months before the study.
  • Poor kindy funciton
  • Severe cardiovascular or other chronic diseases
  • Patients with type I or II diabetes
  • Poor compliance
  • Alcohol abuser
  • Using anti-diabetic or weight managent supplements
  • Blood transfusion three months before the study
  • Pumpkin seed allergy

Study Design

Total Participants: 60
Treatment Group(s): 3
Primary Treatment: Pumpkin seed extract (High dose)
Phase:
Study Start date:
March 01, 2023
Estimated Completion Date:
October 31, 2024

Connect with a study center

  • WanFang Hospital

    Taipei, 116
    Taiwan

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.